Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

PURPOSE: The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease can be ablated. However, long-term randomized data that test this paradigm are lacking. METHODS: We enrolled patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Palma, David A., Olson, Robert, Harrow, Stephen, Gaede, Stewart, Louie, Alexander V., Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George B., Yaremko, Brian P., Schellenberg, Devin, Ahmad, Belal, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Schlijper, Roel, Bauman, Glenn S., Laba, Joanna, Qu, X. Melody, Warner, Andrew, Senan, Suresh
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
RAPID COMMUNICATIONS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7460150/
https://ncbi.nlm.nih.gov/pubmed/32484754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00818
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados